воскресенье, 16 сентября 2012 г.

Agreements roundup.(Home Access Health and American Diabetes Assoication enter agreement)(Cholestech and Onsite Health Diagnostics partnership) - Medical Device Week

Agreements roundup

Home Access in pact with ADA for cardiometabolic risk factors

A Medical Device Daily Staff Report

Home Access Health (Hoffman Estates, Illinois), a personalized diagnostics company, said it has entered into a multi-year relationship with the American Diabetes Association (ADA; Alexandria, Virginia) to increase the prevention and detection of 'cardiometabolic' risk factors, which pose a danger to good health and can lead to the development of Type 2 diabetes and heart disease. Through community-based screenings, this effort will target faith-based and employer wellness programs, the company said.

ADA and its subsidiary, Shaping America's Health, will co-brand Home Access' next-generation home kits with ADA's 'CheckUp America' initiative which focuses on helping Americans lower their diabetes and heart disease risk.

The factors which comprise one's 'cardiometabolic risk' include, high blood glucose, high LDL (bad) cholesterol, high triglycerides, low HDL (good) cholesterol, high blood pressure, smoking, being overweight and physical inactivity. Those screened for cholesterol, diabetes and blood pressure will receive their test results from Home Access and follow-up consultation through Home Access' call center.

This collaboration integrates proven methodologies for managing and lowering health risks through health risk assessments, highly-accurate diagnostics testing, medical counseling, referrals, and patient support services, according to Home Access Health.

In other agreements news: Cholestech (Hayward, California), a provider of alternate site health management solutions for chronic disease, said it has teamed up with Onsite Health Diagnostics (Southlake, Texas), a provider of on-site corporate health screenings. The agreement, valued at an estimated $3 million dollars over the next three years, establishes Cholestech LDX testing system as the preferred device for Onsite screeners to monitor for risk factors associated with stroke, heart disease, diabetes and inflammatory disorders.

Onsite says it brings state-of-the-art sonograms, screening equipment and technicians to the workplaces, at a fraction of the cost charged by hospitals and physicians with minimal interruption. Onsite offers similar services to government agencies, pharmaceutical manufacturers and other organizations.

Onsite screeners will use the LDX system to provide employees with results for a complete lipid panel, blood glucose and high sensitivity C-reactive protein. A complete lipid panel measures three different kinds of lipids in the blood: LDL, HDL and triglycerides, all of which are related to cholesterol, a type of fat. The health professional collects a blood sample using a simple fingerstick, inserts a cassette into the portable LDX system, and receives results within minutes. SOURCE-Medical Device Daily